US HHS announces $20 million in funding to end HIV epidemic

24 August 2022
hhsbig

US Department of Health and Human Services (HHS) Secretary Xavier Becerra has announced more than $20 million in funding to expand HIV prevention, testing, and treatment services at health centers nationwide.

The funding is being awarded by the Health Resources and Services Administration (HRSA) to expand HIV prevention, testing, and treatment services at 64 health centers. It is part of HHS’ Ending the HIV Epidemic in the US (EHE) initiative, which aims to reduce the number of new HIV infections in the USA by 90% by 2030.

Health centers who receive this funding will leverage it to expand access to medication to prevent HIV (including Pre-Exposure Prophylaxis or PrEP and related services), connect people to care, and ensure care services are well coordinated. They will also leverage it to strengthen partnerships with community organizations such as HRSA’s Ryan White HIV/AIDS Program-funded organizations and health departments. Stronger partnerships will speed up patients’ connections to prevention services, including testing and PrEP.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Today's issue

Company Spotlight





More Features in Pharmaceutical